Coronavirus patent latest to complicates treatment

The following is an edited excerpt.

The outbreak of a novel coronavirus in the Middle East is raising worldwide health concerns and triggering questions about the ability of organizations to patent the genetic sequences of diseases for profit.

The virus was identified three months after the Erasmus Medical Center in Rotterdam, Netherlands, acquired a sample of it. The center has taken out a patent on the virus’s genetic sequence.

While Saudi officials and the WHO have said the patent will impede the process of containing the virus and developing treatments, Erasmus has defended the move.

Read the full story here: Can you patent a disease?

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend